rs114549781
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001113378.2(FANCI):c.3865A>G(p.Ile1289Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000283 in 1,614,050 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001113378.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00143 AC: 218AN: 152142Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000350 AC: 88AN: 251470Hom.: 1 AF XY: 0.000250 AC XY: 34AN XY: 135904
GnomAD4 exome AF: 0.000163 AC: 238AN: 1461790Hom.: 0 Cov.: 30 AF XY: 0.000135 AC XY: 98AN XY: 727202
GnomAD4 genome AF: 0.00143 AC: 218AN: 152260Hom.: 1 Cov.: 31 AF XY: 0.00132 AC XY: 98AN XY: 74466
ClinVar
Submissions by phenotype
Fanconi anemia Benign:2
- -
- -
not specified Benign:1
Variant summary: FANCI c.3865A>G (p.Ile1289Val) results in a conservative amino acid change located in the FANCI solenoid 4 domain (IPR029314) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 251470 control chromosomes, predominantly at a frequency of 0.004 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 14 fold of the estimated maximal expected allele frequency for a pathogenic variant in FANCI causing Fanconi anemia phenotype (0.00028), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.3865A>G in individuals affected with Fanconi anemia, complementation group I and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:1
FANCI: BS2 -
Fanconi anemia complementation group I Benign:1
- -
FANCI-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at